SCHEMBL29960692

SCHEMBL29960692

CCOC(=O)C(CC(=O)O)C1CCOc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
MAPT P10636 3/20 0.39
MAPK1 P28482 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 3/20 0.38
KDM4E B2RXH2 1/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A3 Q01959 3/20 0.38
SLC6A4 P31645 2/20 0.38
CYP2D6 P10635 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.36
SSTR4 P31391 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29960844 0.85 SSTR4 (0.40) ALDH1A1MAPTMAPK1CYP3A4CYP2C19
SCHEMBL23934537 0.79 TSHR (0.36) ALDH1A1MAPTMAPK1CYP3A4CYP2C19
SCHEMBL7961253 0.79 FFAR1 (0.49) TSHRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL7961254 0.79 FFAR1 (0.49) TSHRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL29072475 0.77 SSTR4 (0.41) ALDH1A1MAPTCYP2C19TSHRCYP1A2
SCHEMBL22325514 0.73 TSHR (0.46) ALDH1A1CYP2C19TSHRKDM4ECYP2D6
SCHEMBL6652443 0.72 SSTR4 (0.41) GAASSTR4
SCHEMBL27894880 0.71 TSHR (0.68) ALDH1A1CYP2C19TSHRKDM4EMEN1
SCHEMBL29960371 0.71 POLB (0.45) ALDH1A1TSHRKDM4ENPC1CYP1A2
SCHEMBL3596582 0.71 POLB (0.45) ALDH1A1TSHRKDM4ENPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed